Stock listing
ABEO Stock Price, News, Filings & Events — Abeona Therapeutics Inc.
Selected listing: ABEO · NASDAQ · USD · US
This page tracks Abeona Therapeutics Inc.'s ABEO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ABEO:NASDAQ. ABEO:NASDAQ is the stock-level entry point for investors researching Abeona Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Abeona Therapeutics Inc. is a public company traded under the ticker ABEO in the American market. The company has a market capitalization of approximately $344.8 million. Abeona focuses on developing gene and cell therapies for various diseases.
- Ticker
- ABEO:NASDAQ
- Asset type
- Stock
- Market cap
- $348.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Abeona Therapeutics Inc. ABEO:NASDAQ stock context
This page tracks Abeona Therapeutics Inc.'s ABEO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ABEO:NASDAQ. ABEO:NASDAQ is the stock-level entry point for investors researching Abeona Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Abeona Therapeutics Inc. is a public company traded under the ticker ABEO in the American market. The company has a market capitalization of approximately $344.8 million. Abeona focuses on developing gene and cell therapies for various diseases.
Latest news from Abeona Therapeutics Inc.
Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update
August 13, 2026
CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®
August 4, 2026
Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®
July 21, 2026
Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
May 13, 2026
Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN®
May 11, 2026
Abeona Therapeutics Inc. earnings calls
Abeona Therapeutics Inc. (ABEO) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
Abeona Therapeutics Inc. (ABEO) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Abeona Therapeutics Inc. (ABEO) Q4 2025 Earnings Call
March 17, 2026 · Replay with transcript and chapters
Abeona Therapeutics Inc. (ABEO) Q3 2025 Earnings Call
November 12, 2025 · Replay with transcript and chapters
Abeona Therapeutics Inc. (ABEO) Q1 2025 Earnings Call
May 15, 2025 · Replay with transcript and chapters
Abeona Therapeutics Inc. (ABEO) Q4 2024 Earnings Call
March 20, 2025 · Replay with transcript and chapters
Research Abeona Therapeutics Inc.
Abeona Therapeutics Inc. investor report
Review AI stock analysis and investor report context for ABEO:NASDAQ.
Abeona Therapeutics Inc. company profile
View the public company page for Abeona Therapeutics Inc. on 6ix.
Abeona Therapeutics Inc. news
Read company news and market updates connected to Abeona Therapeutics Inc..
Abeona Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Abeona Therapeutics Inc..
Alternate listings
PCJ:GETTEX
DE · EUR
Alternate listing for Abeona Therapeutics Inc.; the primary context on this page is ABEO:NASDAQ.
PCJ:TRADEGATE
DE · EUR
Alternate listing for Abeona Therapeutics Inc.; the primary context on this page is ABEO:NASDAQ.
A3DMHM:LS
DE · EUR
Alternate listing for Abeona Therapeutics Inc.; the primary context on this page is ABEO:NASDAQ.
A3DMHM:LSX
DE · EUR
Alternate listing for Abeona Therapeutics Inc.; the primary context on this page is ABEO:NASDAQ.
0H7R:LSE
GB · USD
Alternate listing for Abeona Therapeutics Inc.; the primary context on this page is ABEO:NASDAQ.
ABEO:BOATS
US · USD
Alternate listing for Abeona Therapeutics Inc.; the primary context on this page is ABEO:NASDAQ.
PCJ:BX
CH · CHF
Alternate listing for Abeona Therapeutics Inc.; the primary context on this page is ABEO:NASDAQ.
PCJ:DUS
DE · EUR
Alternate listing for Abeona Therapeutics Inc.; the primary context on this page is ABEO:NASDAQ.
PCJ:FWB
DE · EUR
Alternate listing for Abeona Therapeutics Inc.; the primary context on this page is ABEO:NASDAQ.
PCJ:HAM
DE · EUR
Alternate listing for Abeona Therapeutics Inc.; the primary context on this page is ABEO:NASDAQ.
PCJ:SWB
DE · EUR
Alternate listing for Abeona Therapeutics Inc.; the primary context on this page is ABEO:NASDAQ.